Reports for LORAZEPAM
Ingredient
LORAZEPAM
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2025-06-13 | 2025-07-03 | 260187 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LORAZEPAM | 0.5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60591 |
| APO-LORAZEPAM | 1MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60594 |
| ATIVAN | 1MG | TABLET | To be discontinued | 2025-10-17 | 2025-10-17 | 269846 |
| ATIVAN | 2MG | TABLET | Discontinued | 2025-10-17 | 2025-11-03 | 269826 |
| ATIVAN | 2MG | TABLET | Discontinued | 2025-10-17 | 2025-11-03 | 269840 |
| ATIVAN | 1MG | TABLET | Discontinued | 2025-10-17 | 2025-11-03 | 269837 |
| ATIVAN | 0.5MG | TABLET | Discontinued | 2025-10-17 | 2025-11-03 | 269831 |
| ATIVAN | 0.5MG | TABLET | To be discontinued | 2025-10-17 | 2025-10-17 | 269843 |
| LORAZEPAM | 0.5MG | TABLET | Reversed | 2017-03-14 | 2017-07-31 | 2430 |
| LORAZEPAM | Discontinued | 2020-02-27 | 2020-02-27 | 107347 |